Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 49,603Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8ASTELLAS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

GILTERITINIB FUMARATE

US Patent Number : 9487491

Drug Substance Claim :

Drug Product Claim :

Application Number : 211349

Patent Use Code : U-2456

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-28

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

GILTERITINIB FUMARATE

US Patent Number : 11938133

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

GILTERITINIB FUMARATE

US Patent Number : 11944620

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

GILTERITINIB FUMARATE

US Patent Number : 11938130

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

GILTERITINIB FUMARATE

US Patent Number : 10786500

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

GILTERITINIB FUMARATE

US Patent Number : 8969336

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-28

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

GILTERITINIB FUMARATE

US Patent Number : 11938131

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

GILTERITINIB FUMARATE

US Patent Number : 11938132

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211349

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-07-01

blank